Therapeutic drug monitoring of anti-TNF-α inhibitor in inflammatory diseases using the N Latex aTNFα assay

Dr. Cattaneo addresses the use of and importance of monitoring anti-TNF-α drugs in patients suffering from rheumatic diseases such as rheumatoid arthritis, inflammatory bowel disease, and psoriasis. As those drugs frequently lose their potency, the ability to detect such loss using functional assays that quantify the concentrations of anti-TNF-α drugs in the patient sample can be very useful for clinicians and patients, who may be prevented from suffering unnecessary pain.

Dario Cattaneo, ASST Fatebenefratelli Sacco University Hospital

Dr. Dario Cattaneo
President, IATDMCT
Unit of Clinical Pharmacology
ASST Fatebenefratelli Sacco University Hospital
Milan, Italy